PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

Despite recent discoveries and therapeutic advances in aggressive myeloid neoplasms, there remains a pressing need for improved therapies. For instance, in acute myeloid leukemia (AML), while most patients achieve a complete remission with conventional chemotherapy or the combination of a hypomethyl...

Full description

Bibliographic Details
Main Authors:	Clifford M. Csizmar, Antoine N. Saliba, Elizabeth M. Swisher, Scott H. Kaufmann
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Cancers
Subjects:	PARP inhibitors acute myeloid leukemia myelodysplastic syndrome myeloid neoplasms secondary malignancies DNA damage repair
Online Access:	https://www.mdpi.com/2072-6694/13/24/6385

Similar Items

Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data
by: Quanfeng Zhao, et al.
Published: (2022-06-01)

What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach
by: Hussein Awada, et al.
Published: (2023-04-01)

Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
by: Nicola Andina, et al.
Published: (2022-01-01)

Current Understanding of <i>DDX41</i> Mutations in Myeloid Neoplasms
by: Kunhwa Kim, et al.
Published: (2023-01-01)

Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” Question
by: Wilma Barcellini, et al.
Published: (2021-09-01)

Karyotypic and fluorescent in-situ hybridization study of the centromere of chromosome 7 in secondary myeloid neoplasms
by: Roberta Sandra da Silva Tanizawa, et al.
Published: (2011-12-01)

Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia
by: S V Gritsaev, et al.
Published: (2016-07-01)

Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data
by: Quanfeng Zhao, et al.
Published: (2022-08-01)

Landscape of genetic alterations of myeloid neoplasms in 305 Chinese cases
by: GOU Yang, et al.
Published: (2019-11-01)

Therapy related acute myeloid leukemia with t(10:16): a rare entity
by: Guldeep K. Uppal, et al.
Published: (2011-12-01)

Characterisation of Myeloid, Lymphiod and Erythroid Cell Lineages in Myelodysplastics Syndrome Using Flow Cytometry
by: Broojerdi, Mohadese Hashem
Published: (2011)

Liquid biopsies and minimal residual disease in myeloid malignancies
by: Sabine Allam, et al.
Published: (2023-05-01)

MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
by: Stephanie Rebecca Setijono, et al.
Published: (2018-01-01)

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
by: Alexander J. Ambinder, et al.
Published: (2022-10-01)

Spine Myeloid Sarcoma: A Case Series with Review of Literature
by: Kajal Shah, et al.
Published: (2021-12-01)

<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
by: Fabio Forghieri, et al.
Published: (2020-11-01)

Clinico-Pathological Findings in Myeloid Malignancies: A Single Center Experience
by: Faheem Ahmed Memon, et al.
Published: (2017-03-01)

Therapy-related myeloid neoplasms as a concerning complication in acute promyelocytic leukemia
by: María del Carmen Vicente-Ayuso, et al.
Published: (2017-09-01)

The Association between PARP1 and LIG3 Expression Levels and Chromosomal Translocations in Acute Myeloid Leukemia Patients
by: Hossein Pashaiefar, et al.
Published: (2018-04-01)

Poly ADP-ribose polymerase (PARP) inhibitors - new therapeutic strategies in Acute Myeloid Leukemia: a literature review
by: Emilia Nowicka, et al.
Published: (2022-12-01)

A model for the functional assessment of elderly with myeloid neoplasms
by: Ana Lúcia Ippolito Carbonell, et al.
Published: (2015-04-01)

DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?
by: Raquel Ordoñez, et al.
Published: (2019-09-01)

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
by: Magdalena M. Brune, et al.
Published: (2021-11-01)

Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
by: Hui Zhang, et al.
Published: (2020-05-01)

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
by: Diego Carbonell, et al.
Published: (2019-09-01)

What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by: Marco Pizzi, et al.
Published: (2023-03-01)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
by: Huai-Hsuan Huang, et al.
Published: (2019-06-01)

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
by: Antonella Padella, et al.
Published: (2022-01-01)

Extracellular Vesicles in Myeloid Neoplasms
by: Christina Karantanou, et al.
Published: (2022-08-01)

Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report
by: Xiaoning Wang, et al.
Published: (2022-11-01)

Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience
by: İbrahim Ethem Pınar, et al.
Published: (2021-03-01)

Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls
by: Nina Winkelmann, et al.
Published: (2022-08-01)

Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging Disease
by: Francesco Mannelli
Published: (2021-01-01)

Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies
by: Alkhatabi HA, et al.
Published: (2024-01-01)

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases
by: Yenny Alejandra Moreno Vanegas, et al.
Published: (2018-09-01)

Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: Michaela Dostalova Merkerova, et al.
Published: (2020-08-01)

Transformation of a myelodysplastic syndrome to acute myeloid leukemia and concurrent necrotizing sweet syndrome
by: Olga Vera-Lastra, et al.
Published: (2021-03-01)

Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology
by: Pablo Gargallo, et al.
Published: (2022-04-01)

Occurrence of Carcinoma of the Pancreas Following Nilotinib Therapy for Chronic Myeloid Leukemia: Report of a Case with Review of the Literature
by: Yasunobu Sekiguchi, et al.
Published: (2015-07-01)

Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China
by: Junnan Li, et al.
Published: (2023-04-01)